Low-Dose Hemibody Radiation, a Treatment Option for Recurrent Prostate Cancer: A Phase 2 Single-Arm Trial

PURPOSE: Nontargeted low-dose ionizing radiation has been proposed as a cancer therapeutic for several decades; however, questions remain about the duration of hematological changes and optimal dosing regimen. Early studies delivering fractionated low doses of radiation to patients with cancer used...

Descripción completa

Detalles Bibliográficos
Autores principales: Dayes, Ian S., Kennedy, Allison E., Parpia, Sameer, Thome, Christopher, Tharmalingam, Sujeenthar, Lemon, Jennifer A., Bowdish, Dawn M.E., Boreham, Douglas R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Scientific Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723318/
https://www.ncbi.nlm.nih.gov/pubmed/36483063
http://dx.doi.org/10.1016/j.adro.2022.101066

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723318/
https://www.ncbi.nlm.nih.gov/pubmed/36483063
http://dx.doi.org/10.1016/j.adro.2022.101066

Ejemplares similares